Cellectar Biosciences Inc. Warrants
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $14,221,336.

Profit Margin

Cellectar Biosciences Inc. Warrants (NASDAQ:CLRBW): Profit margin
2010 33.33M 2.09B 6286.05%
2011 44.47K -7.43M -16716.7%
2012 44.47K -7.43M -16716.7%
2013 0 -10.78M
2014 0 -8.05M
2015 0 -5.49M
2016 0 -6.18M
2017 0 -13.56M
2018 0 -13.23M
2019 0 -14.09M

CLRBW Income Statement (2010 – 2019)

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Revenue
Revenue
000000044.47K44.47K33.33M
Cost of revenue
0000000000
Gross profit
000000044.47K44.47K33.33M
Operating exp.
Research and development
8.99M6.83M9.46M4.75M5.15M5.96M6.86M3.59M3.59M2.99B
Selling and marketing
0000000000
Total operating expenses
14.22M11.68M13.61M9.45M8.55M9.22M11.29M6.60M6.60M5.48B
Operating income
-14.17M-13.33M-13.60M-9.44M-8.75M-9.89M-12.40M-7.03M-7.03M-5.45B
Other income (expenses), net
85.71K91.73K38.68K3.26M3.26M1.83M1.61M708.59K397.70K-7.54B
Income before tax
-14.09M-13.23M-13.56M-6.18M-5.49M-8.05M-10.78M-6.32M-7.43M2.09B
Income tax expense
85.71K91.73K38.68K3.26M3.26M1.83M1.61M1.10M00
Net income
-14.09M-13.23M-13.56M-6.18M-5.49M-8.05M-10.78M-7.43M-7.43M2.09B
Earnings per share
Basic EPS
-1.5-4.47-1.44-0.66-6.4-9.38-0.00-0.00-8.660.01
Diluted EPS
-1.5-4.47-0.97-1.36-6.4-1.75-0.00-0.00-0.190.01
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source